Continuing Pharmacy Education / CE Master List / Law: Boosting Safety by Closing Loopholes-Recorded Webinar
Please use this button to register in our system as a new user, or to purchase a CE Activity.
For free CE's, returning users can simply click the "TAKE TEST/EVALUATION" button on the right.
Please use this button when you have completed the CE Activity and are ready to take the quiz and complete the evaluation.

Law: Boosting Safety by Closing Loopholes-Recorded Webinar

About this Course

This course is a recorded (home study version) of the CE Finale Encore Webinars.

 

Learning Objectives

Upon completion of this knowledge based CE Activity, a pharmacist will be able to:

·       Describe how the FDA is currently funded and the implications for patient safety
·       Describe how the nation’s inability to control concierge or internet prescription drug purchasing endangers patients
·       Describe how the DSHEA act has placed patients in danger from adulterated or contaminated dietary supplements
·       Describe how foreign inspections of manufacturing plants are separate and unequal and jeopardize patient health
·       Describe how relying on the Interstate Commerce Act allows pharmaceutical companies to circumvent research subject protections overseas
·       Describe how to remedy or ameliorate these issues

Release and Expiration Dates

Released:  December 20, 2021
Expires:  December 17, 2024

Course Fee

$15 Pharmacist

ACPE UAN

0009-0000-21-052-H03-P

Session Code

21RW52-ABC28

Accreditation Hours

1.0 hours of CE

Additional Information

 

How to Complete Evaluation:  When you are ready to submit quiz answers, go to the BLUE take test/evaluation button.

Accreditation Statement

The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive up to 1.0 CE Hours (or 0.1 CEUs)  for completing the activity ACPE UAN 0009-0000-21-052-H03-P, passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

Grant Funding

There is no grant funding for this activity.

Faculty

C. Michael White, PharmD, FCCP, FCP
BOT Distinguished Professor
Chair of Pharmacy Practice
University of Connecticut School of Pharmacy
Storrs, CT              

Faculty Disclosure

In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

  • C. Michael White has no relationships with ineligible companies

Disclaimer

The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Content

POST TEST

1. Why did the FDA start applying user fees to manufacturers and what percentage of overall FDA funding comes from the companies they oversee?
A. Because of the HIV/AIDS crisis – 65% of funds come from manufacturer fees
B. Because of the HIV/AIDS crisis – 45% of funds come from manufacturer fees
C. Because of the ebola crises – 45% of funds come from manufacturer fees

2. What is the primary way that people are accessing counterfeit drugs?
A. Through the local community or retail pharmacy
B. Through a licensed domestic mail order pharmacy
C. Through an unlicensed foreign mail order pharmacy

3. Which of the following is a validated way to assure a dietary supplement does not have excessive microbial or heavy metal contamination and has the ingredient in the tablets/capsules advertised on the label?
A. Selecting a product with USP certification
B. Looking for Better Homes and Gardens Certification
C. Buying the most expensive product

4. What occurred simultaneously with the increase in foreign manufacturing site FDA inspections that attenuates the safety benefits to the US patient?
A. A reduction in domestic inspections
B. A lower caliber of foreign inspections
C. A reduction in the FDA inspector workforce

5. What are the risks associated with drug trials shifting overseas?
A. Ethical violations or subject harm will become more prevalent
B. The FDA will have insufficient dataset about risk/benefit balance
C. American jobs will be lost in part due to an unequal playing field
D. All of the above

Handouts

Download

VIDEO